Skip to main content
. 2020 Jul 16;11:3569. doi: 10.1038/s41467-020-17060-4

Fig. 5. CD34+ cells isolated from two MAM-negative whole blood samples, P9 (red) and P10 (blue) and cultured under explicit proliferation conditions following the three-stage protocol described by Griffiths et al.18 in two ex vivo cell culture experiments showed enhanced erythroid proliferation compared to their respective age and gender-matched controls (C1 and C2).

Fig. 5

a Standardised cumulative fold proliferation of erythroid cells in cultures. In each experiment, all samples were maintained at equal cell densities, with passaging carried out as necessary. MAM-negative cultures showed greater expansion compared to the averaged expansion of their respective controls (7.5-fold greater in P9 and 4.62-fold greater in P10 on day 21). Proliferation data from additional cell culture experiments with P9 and P10 supported these findings and are presented in Supplementary Fig. 6. Source data are provided as a Source Data file. b As cell cultures were adjusted to maintain equal cell densities, markedly different final volumes were obtained at the end of the culture. On day 21, enucleation rates of both MAM-negative and control samples were approximately 70%. All samples (total volumes) were filtered using a standardised filtration protocol. Purity of resulting reticulocyte population was >99.2% in all samples. Comparison of packed cell pellets of filtered reticulocytes reflected the greater proliferation capabilities observed in the MAM-negative cultures. c The morphological profiles of the MAM-negative and matched control cells at different stages of erythroid cultures were very similar. No significant differences in the erythroid cell types between MAM-negative and matched controls were observed, with the exception of P9 and P10 reticulocytes (ANOVA repeat measures; P = 0.01), suggesting that the prevalence of each cell type remained constant between the cultures. Therefore, the enhanced MAM-negative cell proliferation was not the result of imbalanced or altered erythroid differentiation. Source data are provided as a Source Data file.